International Journal of Drug Policy

Article	Citations
Publisher's Note	273
Editorial Board	103
Older age at smoking initiation predicts successful cessation in adults who smoke: A prospective study	72
Incarceration history, antiretroviral therapy, and stigma: A cross-sectional study of people with HIV who inject drugs in St. Petersburg, Russia	70
Opioid prescribing restrictions and opioid use among the Louisiana Medicaid population	64
Doing more with less: A proposal to advance cigarette packaging regulations in the United States	59
Editorial Board	57
Editorial Board	57
Editorial Board	55
Co-designing the INHSU Prisons Hepatitis C Advocacy Toolkit using the Advocacy Strategy Framework	52
A content analysis of cannabis edibles package marketing in the United States	50
Identifying barriers and enablers to opt-out hepatitis C virus screening in provincial prisons in Quebec, Canada: A multilevel, multi-theory informed qualitative study with correctional and healthcare	47
Diversion of medications to treat opioid use disorder: Qualitative findings from formerly incarcerated adults in Massachusetts	46
Editorial Board	45
Ecological dimensions of cannabis regulation in the Rif, Morocco	44
The social-structural contexts of cannabis consumption and harm reduction among young Nigerian women	43
Quasi-experimental study on the impact of local smoke-free policies on smoking among Indonesian adults: Evidence from repeated national health surveys	42
Increased solitary drug use during COVID-19: An unintended consequence of social distancing	41
A comprehensive analysis of jurisdiction-specific laws related to scheduling or required prescription drug monitoring of gabapentin in the United States, 2016–2024	41
Contentious legality in decentralized governance: The rise and decline of cannabis social clubs in Spain	40
Inconsistencies between national drug policy and professional beliefs about psychoactive drugs among psychiatrists in the United States	40
Impact of the COVID-19 pandemic on the provision of take-home doses of opioid agonist therapy in Ontario, Canada: A population-based time-series analysis	38
Leveraging pooled medical examiner records to surveil complex and emerging patterns of polysubstance use in the United States	38
Barriers to evidence-based alcohol policies in France: Insights from interviews with parliament members	37
International property rights for Cannabis landraces and terroir products. The case of Moroccan Cannabis and hashish	37

Impact of health policies on opioid tapering and discontinuation among patients receiving long-term opioid therapy for chronic noncancer pain	36
Bridging the gap: An environmental scan of post-overdose program features and evaluation measures	36
‘Choice’ of social media platform or encrypted messaging app to buy and sell illegal drugs	35
Social-spatial network structures among young urban and suburban persons who inject drugs in a large metropolitan area	35
The introduction of fentanyl on the US–Mexico border: An ethnographic account triangulated with drug checking data from Tijuana	35
Trends in the use of cannabis products in Canada and the USA, 2018 – 2020: Findings from the International Cannabis Policy Study	34
Opioid agonist therapy engagement and crystal methamphetamine use: The impact of unregulated opioid use in Vancouver, Canada	34
Medication for opioid use disorder treatment continuity post-release from jail: A qualitative study with community-based treatment providers	34
Higher methadone dose at time of release from prison predicts linkage to maintenance treatment for people with HIV and opioid use disorder transitioning to the community in Malaysia	33
Ethical justifications for safe supply interventions	32
How do patient, pharmacist and medication characteristics and prescription drug monitoring program alerts influence pharmacists' decisions to dispense opioids? A randomised controlled factorial experi	31
A readiness assessment for the prevention of alcohol-related harm in West Africa: A new methodological approach to inform practice and policy	30
The effectiveness of the communities that HEAL intervention on reducing non-fatal opioid overdoses: A prespecified secondary analysis of a waitlist cluster control randomized controlled trial	30
Associations of hepatitis C virus (HCV) antibody positivity with opioid, stimulant, and polysubstance injection among people who inject drugs (PWID) in rural U.S. communities	30
Cannabis reduction among adolescents as spillover from successful tobacco control	30
‘As for dignity and respect…. me bollix’: A human rights-based exploration of service user narratives in Irish methadone maintenance treatment	29
Putting tendencies and trajectories to work: useful tools for engaging with accounts of change and recovery?	29
Likelihood of using a harm reduction vending machine among rural people who inject drugs in Appalachian Kentucky	29
Changes in arrests following decriminalization of low-level drug possession in Oregon and Washington	28
Does cannabis testing in the military drive synthetic cannabinoid use? Self-reported use motivations among justice-involved veterans	28
Applying a mutual capacity building model to inform peer provider programs in South Africa and the United States: A combined qualitative analysis	28
Playing at the edges, navigating sexual boundaries, and narrating sexual distress; Practices and perspectives of sexuality and gender diverse people who use GHB	28
Strategies for addressing needle debris: A scoping review of needle debris and discarded drug paraphernalia associated with substance use	28
A stakeholder-driven framework for measuring potential change in the health risks of people who inject drugs (PWID) during the COVID-19 pandemic	28
Global cannabis cultivation as a gendered activity: Findings from the 2020 International Cannabis Cultivation Questionnaire	28
Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs: The ETHOS Engage study	28
The hammer and the nail: The triple lock of methods, realities and institutional contexts in Australian research on nightlife violence	28
Parenting and heavy substance use: From neutralization theory to actor-network theory to avoid stigmatizing participants	27
Stronger isn’t always better: Nalmefene in community overdose response and the false promise of quick-fix public health solutions	27
Does diverting minor drug offenders reduce recidivism? Cannabis cautioning in Australia	26
Comparing police use of drug detection dogs amongst injecting and non-injecting groups of people who regularly use drugs in Australia	25
Drug markets and violence in Colombia: Where do we stand, and how do we move forward?	25
Speed and smoking kill: A time-varying survival analysis linking methamphetamine use, cigarette smoking, and mortality in sexual minority men	25
Big business: The private sector market for image and performance enhancing drug harm reduction in the UK	25
Buprenorphine dispensing before and after the April 2021 X-Waiver exemptions: An interrupted time series analysis	25
Quantitative controls on the number and/or location of alcohol retail outlets: an overview of approaches in the USA and Canada	25
Transnational alcohol corporations in Nigeria as commercial determinants of health: Implications for policy	25
Impact of alcohol excise taxation and structural reforms on per capita consumption in Thailand, 1995–2021: an interrupted time-series analysis	25
The practice and embodiment of “goofballs”: A qualitative study exploring the co-injection of methamphetamines and opioids	25
Societal costs of illegal drug use in Sweden	25
Psychosocial stress and methamphetamine use: A mixed-methods study of intersectional stigma and Aboriginal and Torres Strait Islander methamphetamine use	25
Updates on syringe coverage and service uptake among needle and syringe programs in the United States, 2019–2020	25
Growing pains: A study of administrative burden and regulatory compliance in German Cannabis Cultivation Associations under the Cannabis Act	24
Spotting as a risk mitigation method: A qualitative study comparing organization-based and informal methods	24
Reluctant risk-takers: how law enforcement practices at festivals can obstruct safer drug use	24
Low daily oral PrEP adherence and low validity of self-report in a randomized trial among PWID in Ukraine	24
Co-located Heroin Assisted Treatment within primary care: A preliminary analysis of the implications for healthcare access, cost, and treatment delivery in the UK	24
Measuring drug policy evolution: A cross-country analysis	23
Trends in young people accessing English alcohol treatment services: 2014 to 2023	23
Confiscations, public health obstructions, and perpetual displacement: Experiences and perspectives on urban law enforcement practices during a period of “recriminalization” among people who use crimi	23

Becoming a nitrous oxide user on social media: Learning to maximise pleasures and minimise harms	23
Are the data good enough? Assessing cocaine markets and indicators in The Netherlands, Denmark, and Sweden	23
Consent and violence amongst men in the context of sexualised drug use: A systematic scoping review	23
Public attitudes and lifetime home cannabis cultivation – a survey after legalization in Germany	23
Do Australians use the prescription pathway when using nicotine vaping products to quit smoking?	23
High levels of all-cause mortality among people who inject drugs from 2018 to 2022	23
From environmental disasters to emerging drugs; a framework to understand, map and assess drug-related early warning systems	22
Vaccination coverage among people who inject drugs: A systematic review	22
Editorial Board	21
Heavy burden of non-fatal overdose among people who inject drugs in San Francisco, 2022	21
Has the treatment gap for opioid use disorder narrowed in the U.S.?: A yearly assessment from 2010 to 2019”	21
Tackling the overdose crisis through unionization: A response to Rivera & Friedman (2024)	21
Municipal socioeconomic environment and recreational cannabis use in Mexico: Analysis of two nationally representative surveys	21
“A never-ending cycle”: The structural, economic and social (re)production of blood-borne virus transmission and bacterial infection amongst people who inject drugs in Queensland prisons	21
Suboptimal uptake and placement of a mandatory alcohol pregnancy warning label in Australia	21
Haven't I waited long enough? The role of wait times and subjective impairment in cannabis-related driving behavior	21
Editorial Board	21
“What I should be doing is harm reduction, if I'm doing my job right”: Engagement with harm reduction principles among prosecutors enacting drug policy reform in the United States	21
Drug transactions and the dark web: Public perceptions of the locational setting of offenders and support for drug policy outcomes	21
Aging and street capital: Older men’s status and strategies in street culture	20
Social and structural determinants of health associated with police violence victimization: A latent class analysis of female sex workers who use drugs in Kazakhstan	20
The relationship between cryptomarket drug purchase, social networks and adverse drug events: A cross-sectional study	20
The geography of drug markets, drug crime and systemic gang violence—Open drug scenes in Sweden	20
Recreational cannabis excise taxation in the USA: Constructing a comparable tax measure for empirical analysis	20
A nationally representative repeated cross-sectional study of 10-year substance use trends among culturally and linguistically diverse Australians	20
Editorial Board	19
Exploring the need for overdose prevention centers in England: A qualitative community-based participatory study on the perspectives of people who use drugs in public and semi-public environments	19
Countering the institutionalization of harm reduction through critical pragmatism	19
The impact of alcohol minimum unit pricing on people with experience of homelessness: Qualitative study	19
Implementing a peer-supported, integrated strategy for substance use disorder care in an outpatient infectious disease clinic is associated with improved patient outcomes	19
Psychedelic discourses: A qualitative study of discussions in a Danish online forum	19
Standard THC units: A tool to benchmark cannabis-related driving risks	19
2S/LGBTQ+ youth substance use and pathways to homelessness: A photovoice study	19
Drugs, guns, and violent crime in California	19
Minimum legal age laws and perceived access to cigarettes, e-cigarettes, and other substances among youth in Canada, England, and the United States: 2017-2021	19
Public support for reinvesting resources from enforcing drug possession to health-promoting alternatives: A nationally representative poll of adults in the United States	19
Interconnected influence: Unraveling purdue pharmaceutical's role in the global response to the opioid crisis	19
Problematizing “patient stability” in opioid use disorder care: Flexible definitions, (in)flexible treatment	19
Scapegoated communities, shared struggles: A call for solidarity with people who use drugs and queer and trans people	19
Intersecting stigmas: How racial attitudes shape support for treatment and harm reduction for people who inject drugs	19
The intersection of substance use stigma and anti-Black racial stigma: A scoping review	18
Appearance of 2-MMC and 3-MMC on the illicit drug market in the Netherlands: A systematic narrative review of the prevalence and risks	18
Naloxone cascade of care among people who regularly inject drugs in Australia, 2020–2022	18
The global epidemiology of injecting drug use, HIV, viral hepatitis and tuberculosis among people who are incarcerated: a multistage systematic review	18
Prevalence of comorbid substance use disorders among people with opioid use disorder: A systematic review & meta-analysis	18
The benefits and challenges of virtual SMART recovery mutual-help groups: Participant and facilitator perspectives	18
Drug use typology, demographic covariates, and associations with condomless anal sex: A latent class analysis among a U.S. national cohort of men who have sex with men	18
Cannabis legalization and changes in cannabis and tobacco/nicotine use and co-use in a national cohort of U.S. adults during 2017–2021	18
Stronger, longer, better opioid antagonists? Nalmefene is NOT a naloxone replacement	18
Slamsex as slow edgework: Sexualized drug use and harm reduction in post-AIDS Taiwan	18
Community-level determinants of stakeholder perceptions of community stigma toward people with opioid use disorders, harm reduction services and treatment in the HEALing Communities Study	18
Wastewater-based evidence of pregabalin misuse in Türkiye: implications for drug policy and surveillance	18
Self-reported and measured adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs: The HERO study	17
“Harm per litre” as a concept and a measure in studying determinants of relations between alcohol consumption and harm	17
Risky alcohol use and violence against women: cause or consequence?	17
Characterizing changes in drug use behaviour following supply shortages of 5-MeO-DIPT, alkyl nitrites and new psychoactive substances among men living with HIV in Japan	17
Access and care for people with opioid use disorder in U.S. skilled nursing facilities: A policy commentary	17
Exploring trauma and wellbeing of people who use drugs after witnessing overdose: A qualitative study	17
Beverage-specific consumption trends: A cross-country, cross-sectional comparison	17
Patients prefer free drug disposal options delivered by pharmacists at the point of care: Results of a decision tree analysis of a national factorial vignette panel survey	17
Pre-implementation findings on the barriers and potential solutions to initiate same-day antiretroviral therapy among people who inject drugs in Malaysia	17
Editorial Board	17
Current regulations in context: Scraping Australia's online nitrous oxide market	17
Post-retirement enlightenment syndrome: Worthy of investigation	17
The association between social capital and drug overdose mortality in the United States	16
Women's experiences in injectable opioid agonist treatment programs in Vancouver, Canada	16
Exploring how an e-cigarette intervention influenced tobacco smoking behaviour in people accessing homelessness services: Findings from the SCeTCH trial process evaluation	16
Adoption of methadone take home policy by U.S. state opioid treatment authorities during COVID-19	16
The impacts of COVID-19 on structural inequities faced by people living with HIV who inject drugs: A qualitative study in St. Petersburg, Russia	16
“I just saw the alcohol brand, I never really thought of the zeros”: Young people’s views of NoLo and alibi alcohol sponsorship	16
Barriers and advocacy needs for hepatitis C services in prisons: Informing the prisons hepatitis C advocacy toolkit	16
Prevalence and engagement with healthcare services for hepatitis B infection among people in prison in Australia: the AusHep study	16
Editorial Board	16
Synergistic effects of exposure to multiple types of violence on non-fatal drug overdose among women who inject drugs in Indonesia	16
A pilot implementation study to scale-up methadone in incarcerated persons with opioid use disorder and retain them on treatment after release in Moldova	16
The importance of PEOPLE who use drugs within drug policy reform debates: Findings from the UK Drug Policy Voices online survey	16
Doubts and disconnection: Police reflections on drug decriminalization in British Columbia in the first year of implementation	16
The Baltic and Nordic responses to the first Taliban poppy ban: Implications for Europe & synthetic opioids today	15
Transitions to legal cannabis markets: Legal market capture of cannabis expenditures in Canada following federal cannabis legalization	15
Editorial - Supporting the best quality science and the rights of people who use drugs regardless of global policy changes: Perspectives from the co-Editors in Chief of the International Journal of Dr	15

Examining the association between trenbolone, psychological distress, and aggression among males who use anabolic-androgenic steroids	15
“It’s not just the hit itself”: the social practice of injecting drug use among gay and bisexual men in Australia	15
Decline in youth drinking in high-income settings: Implications for public health in low-income countries	15
System dynamics modeling to inform implementation of evidence-based prevention of opioid overdose and fatality: A state-level model from the New York HEALing Communities Study	15
Beyond the smoke: Historical analysis of the revenue implications of state cigarette tax policies, 1989 to 2019	15
Through the wine glass: How biographical midlife transitions and women's affective interpretations interact with alcohol consumption	15
Facilitating access to direct-acting antivirals in a community-based point-of-diagnosis model for hepatitis C treatment: The role of the pharmacy team in the no one waits (NOW) study	15
Hepatitis C treatment in a jail setting: A retrospective cohort analysis of low-barrier initiation of direct acting antivirals	14
Corrigendum to ‘Substances from unregulated drug markets – A retrospective data analysis of customer-provided samples from a decade of drug checking service in Zurich (Switzerland)’ [Volume 114, April	14
Dublin’s supervised injecting facility: An assessment of its impact on discarded needles	14
Drug treatment and support service utilization amidst the COVID-19 pandemic among people who inject drugs in Baltimore, Maryland: An interrupted time-series analysis, 2015–2022	14
Leveraging web-scraped data to examine alcohol pricing: an Australian feasibility study with retail data	14
“It should be hard to be a drug abuser” An evaluation of the criminalization of drug use in Sweden	14
Editorial Board	14
Anti-doping measures in gyms and fitness centres: A mapping of practices in the state parties of the council of Europe’s anti-doping convention	14
Voices represented and voices silenced: Represented voices in the media coverage of the implementation of a supervised injecting facility	14
“I've lost my children to vaping”: A frame analysis of the Australian media's construction of the “Youth vaping crisis”	14
Scoping review of the characteristics and implementation of routine outcome monitoring and feedback for adults and young people accessing alcohol and other drug use treatment	14
Substances from unregulated drug markets – A retrospective data analysis of customer-provided samples from a decade of drug checking service in Zurich (Switzerland)	13
‘Red Flags’ and ‘Red Tape’: Telehealth and pharmacy-level barriers to buprenorphine in the United States	13
Disentangling opioids-related overdose syndemics: a scoping review	13
Drug policy goals in a changing landscape: Perspectives of practitioners in Japan	13
The economic factors that determine smoking abstinence: a survival and mediation analysis	13
A call for compassionate opioid overdose response	13
Corrigendum to “Sociological investigations of human enhancement drugs: The case of microdosing psychedelics” [International Journal of Drug Policy 95 (2021) 103099]	13
Pipes as an engagement tool: qualitative findings from a crack equipment and harm reduction training intervention in England	13
Neutral attitude toward the utilization of psychedelic therapy for depression in the United Kingdom population	13
‘Some days I am a lunatic that thinks I can moderate’: Amalgamating recovery and neo-liberal discourses within accounts of non-drinking among women active in the ‘positive sobriety’ community on Insta	13
Impact of COVID-19 on the characteristics of opioid overdose deaths in Arkansas	13
Volatile substances are an amorphous category, making it hard to build a comprehensive body of research	13
Unpacking the differing understandings of “alcohol industry” in public health research	13
Radical hospitality: Innovative programming to build community and meet the needs of people who use drugs at a government-sanctioned overdose prevention site in San Francisco, California	13
96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial	13
Recovery as a minor practice	13
Community-administered naloxone for overdose reversal: The role of sex worker-led programming and occupational violence in a community-based cohort (2018–2024)	13
Changing Trends in Nonmedical Gabapentin Use Among a Cohort of Rural Appalachian People Who Use Drugs: A Longitudinal Study Over the Time Period of Scheduling Changes in Kentucky	13
Association between U.S. state prenatal drug use laws and child welfare reporting in Alabama, Maryland and Utah	13
Defining a public health approach to substance use: Perspectives from professionals and practitioners across Canada	13
Decrease in provider stigma is associated with improved quality health indicators among individuals receiving methadone in primary care centers in Ukraine	13
Monitoring for fentanyl within Australian supervised injecting facilities: Findings from feasibility testing of novel methods and collaborative workshops	13
“There’s a lot of stereotypes going on”: A cross-national qualitative analysis of the place of gender in declining youth drinking	13
From Anti-doping-I to Anti-doping-II: Toward a paradigm shift for doping prevention in sport	12
Public calls for service to the police: Trends before and during drug possession decriminalization in Oregon	12
The role of gifts in building influence with politicians: Thematic analysis of interviews with current and former parliamentarians	12
Alcohol policy changes during the first three-months of the COVID-19 pandemic: Development and application of a classification scheme	12
Where to next? An exploration of ‘night-out’ location progression and propensity to experience violence in night -time entertainment precincts	12
‘I don’t really want to speak up because they’re on a different level to me’: The stigma of not engaging in trauma talk	12
Editorial Board	12
Policy actor views on structural vulnerability in harm reduction and policymaking for illegal drugs: A qualitative study	12
Optimal provision of opioid agonist therapy (OAT) and needle and syringe programmes (NSP): a realist evaluation	12
The effectiveness of smoking cessation interventions in rural and remote populations: Systematic review and meta-analyses	12
Long-term patterns of treatment use for opioid use disorder (OUD): Findings from the 18-20-year Australian Treatment Outcome Study	12
Hepatitis C incidence among patients attending primary care health services that specialise in the care of people who inject drugs, Victoria, Australia, 2009 to 2020	12
Psychomodulatory substances: New legislative framework for control of psychoactive substances in Czechia	12
The Impact of Communicating the Benefits and Safety of Psilocybin on Policy Support: a Survey Based Experiment	12
Not just fentanyl: Understanding the complexities of the unregulated opioid supply through results from a drug checking service in British Columbia, Canada	12
Framing drug policy reform: Third-sector advocacy and the 2024 New South Wales Drug Summit	12
A cost-effectiveness analysis of a multidisciplinary model of care on hepatitis C care among people released from provincial prison in Quebec, Canada	12
Can alcohol policy prevent harms to women and children from men's alcohol consumption? An overview of existing literature and suggested ways forward	12
Connecting patients notified with hepatitis C to treatment (CONNECT Study): A randomized controlled trial of active case management by a health department to support primary care practitioners	12
“COVID just kind of opened a can of whoop-ass”: The rapid growth of safer supply prescribing during the pandemic documented through an environmental scan of addiction and harm reduction services in Ca	12
A concept mapping study of service user design of safer supply as an alternative to the illicit drug market	12
Implementation of a multi-component alcohol policy in Ireland: A qualitative study exploring barriers and facilitators to implementation	11
Using modelling and public health surveillance data to evidence progress towards the WHO incidence target for hepatitis C elimination in people who inject drugs - a review of complementary approaches	11
Sex-specific trends in patterns of tobacco and nicotine use among young people in Denmark from 2020 to 2023: A multigroup latent class analysis	11
Understanding the longitudinal relationship between substance use and violent victimization among street-based women who exchange sex in Baltimore, Maryland	11
Policing and drug market-related violence: competitive, internal and enforcement-related violence in UK County Lines	11
Public transport access to drug treatment before and during COVID-19: Implications for the opioid epidemic	11
Stimulant-involved overdose deaths: Constructing dynamic hypotheses	11
Trends and correlates of naloxone possession and use among people who inject drugs in Seattle, Washington	11
Cannabis industry campaign expenditures in Colorado, 2005-2021	11
Unlocking deflection: The role of supervisor support in police officer willingness to refer people who inject drugs to harm reduction services	11
Youth Transitions and the Politics of Risk: Schooling amid Drug-related Violence in Mexico City	11
Factors associated with attending “open bar” parties amongst early adolescents	11
Multilevel determinants of cannabis prices in legal markets: Evidence from products sold in nearly 4000 cannabis dispensaries in the United States	11
Editorial Board	11
‘I just thought that was the best thing for me to do at this point’: Exploring patient experiences with depot buprenorphine and their motivations to discontinue	11
Like birds of a feather? A multi-case study on the connections between cannabis, tobacco, alcohol and pharmaceutical companies in legalized cannabis markets	11
Assessing options for cannabis law reform: A Multi-Criteria Decision Analysis (MCDA) with stakeholders in New Zealand	11
Corrigendum to “Risky alcohol use and violence against women: cause or consequence?” [International Journal of Drug Policy 145 (2025) 104981]	11
Editorial Board	11
Programmatic alcohol advertising, social media and public health: Algorithms, automated challenges to regulation, and the failure of public oversight	11
Safer supply programs: Discussions on medication diversion, sharing, and selling	11
Are dietary supplement users more likely to dope than non-users?: A systematic review and meta-analysis	11
Factors associated with hepatitis C testing, treatment, and current hepatitis C infection among men and women who inject drugs: The ETHOS engage study	11
Policing and access to harm reduction services among young people who use drugs and young Indigenous people who use drugs before and after the pilot implementation of decriminalization of personal pos	11
“Apparently, you can only be treated once”: A qualitative study exploring perceptions of hepatitis C and access to treatment among people who inject drugs visiting a needle and syringe program	11
Using synthetic controls to estimate the population-level effects of Ontario's recently implemented overdose prevention sites and consumption and treatment services	11
What can we learn from low-THC cannabis growers in Europe? A comparative transnational study of small-scale cannabis growers from Italy and Switzerland	11
Is the affordability of cigarettes associated with the prevalence of smoking and quitting at the regional level in Russia?	11
Multidimensional assessment of access to medications for opioid use disorder across urban and rural communities: A scoping review	11
The Züri Can study: Can regulated cannabis sales promote lower-risk cannabis use? Mini-review and study protocol	10
Factors associated with experiencing stigma, discrimination, and negative health care treatment among people who inject drugs	10
Impacts of the COVID-19 pandemic on enrollment in medications for opioid use disorder (MOUD) in Vancouver, Canada: An interrupted time series analysis	10
Using drugs alone in single room occupancy housing: Understanding environmental drivers of overdose risk	10